Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.

Nawaz I, Hu LF, Du ZM, Moumad K, Ignatyev I, Pavlova TV, Kashuba V, Almgren M, Zabarovsky ER, Ernberg I.

Oncotarget. 2015 Oct 13;6(31):31493-507. doi: 10.18632/oncotarget.5154.

2.

Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.

Prudnikova TY, Soulitzis N, Kutsenko OS, Mostovich LA, Haraldson K, Ernberg I, Kashuba VI, Spandidos DA, Zabarovsky ER, Grigorieva EV.

Cancer Med. 2013 Oct;2(5):654-61. doi: 10.1002/cam4.108. Epub 2013 Aug 5.

3.

D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.

Rosenberg EE, Prudnikova TY, Zabarovsky ER, Kashuba VI, Grigorieva EV.

Tumour Biol. 2014 Apr;35(4):3237-45. doi: 10.1007/s13277-013-1423-6. Epub 2013 Nov 22.

PMID:
24264315
4.

Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform.

Midtvedt T, Zabarovsky E, Norin E, Bark J, Gizatullin R, Kashuba V, Ljungqvist O, Zabarovska V, Möllby R, Ernberg I.

PLoS One. 2013 Jun 20;8(6):e66074. doi: 10.1371/journal.pone.0066074. Print 2013.

5.

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.

Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.

6.

NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA, Yenamandra SP, Lerman M, Senchenko VN, Zabarovsky E.

Int J Mol Sci. 2012 Oct 18;13(10):13352-77. doi: 10.3390/ijms131013352.

7.

Alterations of the WNT7A gene in clear cell renal cell carcinomas.

Kondratov AG, Kvasha SM, Stoliar LA, Romanenko AM, Zgonnyk YM, Gordiyuk VV, Kashuba EV, Rynditch AV, Zabarovsky ER, Kashuba VI.

PLoS One. 2012;7(10):e47012. doi: 10.1371/journal.pone.0047012. Epub 2012 Oct 8.

8.

miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues.

Prudnikova TY, Mostovich LA, Kashuba VI, Ernberg I, Zabarovsky ER, Grigorieva EV.

Epigenetics. 2012 Oct;7(10):1109-14. doi: 10.4161/epi.22103. Epub 2012 Sep 11.

9.

The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.

Mostovich LA, Prudnikova TY, Kondratov AG, Gubanova NV, Kharchenko OA, Kutsenko OS, Vavilov PV, Haraldson K, Kashuba VI, Ernberg I, Zabarovsky ER, Grigorieva EV.

Epigenetics. 2012 Aug;7(8):930-9. doi: 10.4161/epi.21199. Epub 2012 Jul 18.

10.

LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma.

Chen H, Ko JM, Wong VC, Hyytiainen M, Keski-Oja J, Chua D, Nicholls JM, Cheung FM, Lee AW, Kwong DL, Chiu PM, Zabarovsky ER, Tsao SW, Tao Q, Kan R, Chan SH, Stanbridge EJ, Lung ML.

Cancer Lett. 2012 Dec 1;325(1):89-98. doi: 10.1016/j.canlet.2012.06.005. Epub 2012 Jun 26.

PMID:
22743615
11.

Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, Klein G, Lerman MI, Zabarovsky ER.

Epigenetics. 2012 May;7(5):502-13. doi: 10.4161/epi.19801. Epub 2012 May 1.

PMID:
22491060
12.

LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.

Haraldson K, Kashuba VI, Dmitriev AA, Senchenko VN, Kudryavtseva AV, Pavlova TV, Braga EA, Pronina IV, Kondratov AG, Rynditch AV, Lerman MI, Zabarovsky ER.

Biochimie. 2012 May;94(5):1151-7. doi: 10.1016/j.biochi.2012.01.019. Epub 2012 Feb 2.

PMID:
22321817
13.

Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties.

Huang Z, Cheng Y, Chiu PM, Cheung FM, Nicholls JM, Kwong DL, Lee AW, Zabarovsky ER, Stanbridge EJ, Lung HL, Lung ML.

Oncogene. 2012 Aug 9;31(32):3709-20. doi: 10.1038/onc.2011.529. Epub 2011 Dec 12.

PMID:
22158051
14.

Methylation pattern of the putative tumor-suppressor gene LRRC3B promoter in clear cell renal cell carcinomas.

Kondratov AG, Stoliar LA, Kvasha SM, Gordiyuk VV, Zgonnyk YM, Gerashchenko AV, Vozianov AF, Rynditch AV, Zabarovsky ER, Kashuba VI.

Mol Med Rep. 2012 Feb;5(2):509-12. doi: 10.3892/mmr.2011.681. Epub 2011 Nov 16.

PMID:
22101383
15.

Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors.

Mostovich LA, Prudnikova TY, Kondratov AG, Loginova D, Vavilov PV, Rykova VI, Sidorov SV, Pavlova TV, Kashuba VI, Zabarovsky ER, Grigorieva EV.

Cell Adh Migr. 2011 Sep-Oct;5(5):395-401. doi: 10.4161/cam.5.5.17949.

16.

Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma.

Law EW, Cheung AK, Kashuba VI, Pavlova TV, Zabarovsky ER, Lung HL, Cheng Y, Chua D, Lai-Wan Kwong D, Tsao SW, Sasaki T, Stanbridge EJ, Lung ML.

Oncogene. 2012 Feb 9;31(6):728-38. doi: 10.1038/onc.2011.272. Epub 2011 Jul 11.

PMID:
21743496
17.

D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.

Grigorieva EV, Prudnikova TY, Domanitskaya NV, Mostovich LA, Pavlova TV, Kashuba VI, Zabarovsky ER.

Br J Cancer. 2011 Jun 28;105(1):74-82. doi: 10.1038/bjc.2011.170. Epub 2011 Jun 7.

18.

Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis.

Cheung AK, Ko JM, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, Tokino T, Kashima L, Suzuki T, Kwong DL, Chua D, Tsao SW, Lung ML.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8390-5. doi: 10.1073/pnas.1101747108. Epub 2011 May 3.

19.

A novel MECA3 region in human 3p21.3 harboring putative tumor suppressor genes and oncogenes.

Braga E, Loginov W, Khodyrev D, Pronina I, Kazubskaya T, Bogatyrova O, Kashuba VI, Senchenko VN, Klein G, Lerman MI, Kisselev LL, Zabarovsky ER.

Exp Oncol. 2011 Mar;33(1):33-41.

PMID:
21423093
20.

Differential expression of CHL1 gene during development of major human cancers.

Senchenko VN, Krasnov GS, Dmitriev AA, Kudryavtseva AV, Anedchenko EA, Braga EA, Pronina IV, Kondratieva TT, Ivanov SV, Zabarovsky ER, Lerman MI.

PLoS One. 2011 Mar 7;6(3):e15612. doi: 10.1371/journal.pone.0015612.

21.

Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.

Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Lung HL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML.

Int J Cancer. 2012 Jan 1;130(1):83-95. doi: 10.1002/ijc.25970. Epub 2011 Apr 20.

22.

Cloning and Initial Functional Characterization of Mlk4α and Mlk4β.

Kashuba VI, Grigorieva EV, Kvasha SM, Pavlova TV, Grigoriev V, Protopopov A, Kharchenko O, Gizatullin R, Rynditch AV, Zabarovsky ER.

Genomics Insights. 2011 Mar 22;4:1-12. doi: 10.4137/GEI.S6092. eCollection 2011.

23.

Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma.

Chan KC, Ko JM, Lung HL, Sedlacek R, Zhang ZF, Luo DZ, Feng ZB, Chen S, Chen H, Chan KW, Tsao SW, Chua DT, Zabarovsky ER, Stanbridge EJ, Lung ML.

Int J Cancer. 2011 Oct 15;129(8):1826-37. doi: 10.1002/ijc.25855. Epub 2011 Apr 1.

24.

Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells.

Prudnikova TY, Mostovich LA, Domanitskaya NV, Pavlova TV, Kashuba VI, Zabarovsky ER, Grigorieva EV.

Cancer Cell Int. 2010 Aug 19;10:27. doi: 10.1186/1475-2867-10-27.

25.

Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas.

Gerashchenko GV, Bogatyrova OO, Rudenko EE, Kondratov AG, Gordiyuk VV, Zgonnyk YM, Vozianov OF, Pavlova TV, Zabarovsky ER, Rynditch AV, Kashuba VI.

Exp Oncol. 2010 Jul;32(2):71-5.

PMID:
20693965
26.

Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.

Lo PH, Lung HL, Cheung AK, Apte SS, Chan KW, Kwong FM, Ko JM, Cheng Y, Law S, Srivastava G, Zabarovsky ER, Tsao SW, Tang JC, Stanbridge EJ, Lung ML.

Cancer Res. 2010 Jul 1;70(13):5567-76. doi: 10.1158/0008-5472.CAN-09-4510. Epub 2010 Jun 15.

27.

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways.

Lock FE, Underhill-Day N, Dunwell T, Matallanas D, Cooper W, Hesson L, Recino A, Ward A, Pavlova T, Zabarovsky E, Grant MM, Maher ER, Chalmers AD, Kolch W, Latif F.

Oncogene. 2010 Jul 29;29(30):4307-16. doi: 10.1038/onc.2010.192. Epub 2010 May 31.

PMID:
20514026
28.

Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.

Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Zabarovsky ER, Roy A, Roychoudhury S, Panda CK.

Cancer Sci. 2010 Jun;101(6):1511-20. doi: 10.1111/j.1349-7006.2010.01551.x. Epub 2010 Feb 4.

29.

Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer.

Gerashchenko GV, Gordiyuk VV, Skrypkina IY, Kvasha SM, Kolesnik OO, Ugryn DD, Pavlova TV, Zabarovsky ER, Rynditch AV, Kashuba VI.

Ukr Biokhim Zh (1999). 2009 Jul-Aug;81(4):81-7.

PMID:
20387637
30.

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI, Lerman MI, Zabarovsky ER.

BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.

31.

Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.

Lung HL, Cheung AK, Cheng Y, Kwong FM, Lo PH, Law EW, Chua D, Zabarovsky ER, Wang N, Tsao SW, Stanbridge EJ, Lung ML.

Int J Cancer. 2010 Jul 15;127(2):304-12. doi: 10.1002/ijc.25047.

32.

RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.

Mitra S, Mazumder Indra D, Bhattacharya N, Singh RK, Basu PS, Mondal RK, Roy A, Zabarovsky ER, Roychoudhury S, Panda CK.

Genes Chromosomes Cancer. 2010 Feb;49(2):155-70. doi: 10.1002/gcc.20726.

PMID:
19885927
33.

Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.

Cheung AK, Lung HL, Ko JM, Cheng Y, Stanbridge EJ, Zabarovsky ER, Nicholls JM, Chua D, Tsao SW, Guan XY, Lung ML.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14478-83. doi: 10.1073/pnas.0900198106. Epub 2009 Aug 10.

34.

High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

Kashuba VI, Pavlova TV, Grigorieva EV, Kutsenko A, Yenamandra SP, Li J, Wang F, Protopopov AI, Zabarovska VI, Senchenko V, Haraldson K, Eshchenko T, Kobliakova J, Vorontsova O, Kuzmin I, Braga E, Blinov VM, Kisselev LL, Zeng YX, Ernberg I, Lerman MI, Klein G, Zabarovsky ER.

PLoS One. 2009 May 29;4(5):e5231. doi: 10.1371/journal.pone.0005231.

35.

Epigenetic analysis of childhood acute lymphoblastic leukemia.

Dunwell TL, Hesson LB, Pavlova T, Zabarovska V, Kashuba V, Catchpoole D, Chiaramonte R, Brini AT, Griffiths M, Maher ER, Zabarovsky E, Latif F.

Epigenetics. 2009 Apr 1;4(3):185-93. Epub 2009 Apr 12.

PMID:
19430199
36.

Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.

Cheung AK, Lung HL, Hung SC, Law EW, Cheng Y, Yau WL, Bangarusamy DK, Miller LD, Liu ET, Shao JY, Kou CW, Chua D, Zabarovsky ER, Tsao SW, Stanbridge EJ, Lung ML.

Cancer Res. 2008 Oct 1;68(19):8137-45. doi: 10.1158/0008-5472.CAN-08-0904.

37.

HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.

Wang F, Grigorieva EV, Li J, Senchenko VN, Pavlova TV, Anedchenko EA, Kudryavtseva AV, Tsimanis A, Angeloni D, Lerman MI, Kashuba VI, Klein G, Zabarovsky ER.

PLoS One. 2008 Aug 22;3(8):e3031. doi: 10.1371/journal.pone.0003031.

38.

Decreased expression of human D-glucuronyl C5-epimerase in breast cancer.

Grigorieva E, Eshchenko T, Rykova VI, Chernakov A, Zabarovsky E, Sidorov SV.

Int J Cancer. 2008 Mar 1;122(5):1172-6.

39.

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

Cooper WN, Dickinson RE, Dallol A, Grigorieva EV, Pavlova TV, Hesson LB, Bieche I, Broggini M, Maher ER, Zabarovsky ER, Clark GJ, Latif F.

Oncogene. 2008 Mar 13;27(12):1805-11. Epub 2007 Sep 24.

40.

Why do we not all die of cancer at an early age?

Klein G, Imreh S, Zabarovsky ER.

Adv Cancer Res. 2007;98:1-16. Review.

PMID:
17433906
41.

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter.

Angeloni D, Danilkovitch-Miagkova A, Ivanova T, Braga E, Zabarovsky E, Lerman MI.

Oncogene. 2007 Jul 5;26(31):4499-512. Epub 2007 Feb 5.

PMID:
17297469
42.

TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma.

Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI, Zabarovsky ER, Tsao SW, Stanbridge EJ, Lung ML.

Cancer Res. 2006 Oct 1;66(19):9385-92.

43.

Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma.

Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML.

Int J Cancer. 2006 Dec 15;119(12):2821-6.

44.

The transcriptional landscape of the mammalian genome.

Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE, Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, Bansal M, Baxter L, Beisel KW, Bersano T, Bono H, Chalk AM, Chiu KP, Choudhary V, Christoffels A, Clutterbuck DR, Crowe ML, Dalla E, Dalrymple BP, de Bono B, Della Gatta G, di Bernardo D, Down T, Engstrom P, Fagiolini M, Faulkner G, Fletcher CF, Fukushima T, Furuno M, Futaki S, Gariboldi M, Georgii-Hemming P, Gingeras TR, Gojobori T, Green RE, Gustincich S, Harbers M, Hayashi Y, Hensch TK, Hirokawa N, Hill D, Huminiecki L, Iacono M, Ikeo K, Iwama A, Ishikawa T, Jakt M, Kanapin A, Katoh M, Kawasawa Y, Kelso J, Kitamura H, Kitano H, Kollias G, Krishnan SP, Kruger A, Kummerfeld SK, Kurochkin IV, Lareau LF, Lazarevic D, Lipovich L, Liu J, Liuni S, McWilliam S, Madan Babu M, Madera M, Marchionni L, Matsuda H, Matsuzawa S, Miki H, Mignone F, Miyake S, Morris K, Mottagui-Tabar S, Mulder N, Nakano N, Nakauchi H, Ng P, Nilsson R, Nishiguchi S, Nishikawa S, Nori F, Ohara O, Okazaki Y, Orlando V, Pang KC, Pavan WJ, Pavesi G, Pesole G, Petrovsky N, Piazza S, Reed J, Reid JF, Ring BZ, Ringwald M, Rost B, Ruan Y, Salzberg SL, Sandelin A, Schneider C, Schönbach C, Sekiguchi K, Semple CA, Seno S, Sessa L, Sheng Y, Shibata Y, Shimada H, Shimada K, Silva D, Sinclair B, Sperling S, Stupka E, Sugiura K, Sultana R, Takenaka Y, Taki K, Tammoja K, Tan SL, Tang S, Taylor MS, Tegner J, Teichmann SA, Ueda HR, van Nimwegen E, Verardo R, Wei CL, Yagi K, Yamanishi H, Zabarovsky E, Zhu S, Zimmer A, Hide W, Bult C, Grimmond SM, Teasdale RD, Liu ET, Brusic V, Quackenbush J, Wahlestedt C, Mattick JS, Hume DA, Kai C, Sasaki D, Tomaru Y, Fukuda S, Kanamori-Katayama M, Suzuki M, Aoki J, Arakawa T, Iida J, Imamura K, Itoh M, Kato T, Kawaji H, Kawagashira N, Kawashima T, Kojima M, Kondo S, Konno H, Nakano K, Ninomiya N, Nishio T, Okada M, Plessy C, Shibata K, Shiraki T, Suzuki S, Tagami M, Waki K, Watahiki A, Okamura-Oho Y, Suzuki H, Kawai J, Hayashizaki Y; FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group).

Science. 2005 Sep 2;309(5740):1559-63. Erratum in: Science. 2006 Mar 24;311(5768):1713.

45.

hUNC-93B1, a novel gene mainly expressed in the heart, is related to left ventricular diastolic function, heart failure morbidity and mortality in elderly men.

Arnlöv J, Sundström J, Lind L, Andrén B, Andersson M, Reneland R, Berglund L, Kashuba V, Protopopov A, Zabarovsky E, Lithell H.

Eur J Heart Fail. 2005 Oct;7(6):958-65. Epub 2005 Aug 18.

46.

High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma.

Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, Jiang JH, Guo C, Zabarovsky E, Ernberg I, Zeng YX.

Cancer Biol Ther. 2005 Oct;4(10):1116-22. Epub 2005 Oct 13.

PMID:
16096369
47.

THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.

Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L, Wang N, Protopopov AI, Zabarovsky ER, Tsao SW, Stanbridge EJ, Lung ML.

Oncogene. 2005 Sep 29;24(43):6525-32.

PMID:
16007174
48.

Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.

Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER.

Cancer Res. 2004 Sep 15;64(18):6438-43.

49.

Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.

Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, Minna JD, Lerman MI, Klein G, Zabarovsky E.

Oncogene. 2004 Aug 5;23(35):5941-9.

PMID:
15208682
50.

Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.

Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, Braga EA, Zabarovsky ER.

Oncogene. 2004 Jul 29;23(34):5719-28.

PMID:
15208675

Supplemental Content

Loading ...
Support Center